<DOC>
	<DOC>NCT00806715</DOC>
	<brief_summary>The goal of this study is to examine the impact of iron overload in patients undergoing a bone marrow transplant. We believe that the iron status in these patients is associated with complications for transplant survivors. We will examine the iron status in these patients by MRI and by screening for mutations in genes known to cause iron overload. We will also determine the levels of hepcidin (a hormone produced in the liver that appears to regulate iron homeostasis) from blood and urine.</brief_summary>
	<brief_title>Iron Overload in Stem Cell Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Iron Overload</mesh_term>
	<criteria>1. Undergoing allogeneic HSCT for malignant or nonmalignant conditions 2. Age greater than or equal to 5 years 3. Able to undergo MRI without a need for general anesthesia 4. No metal implants 5. Signed informed consent (by parent if patient is less than 18 years old, or by patient, if he or she is greater than 18 years old).</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>hemochromatosis</keyword>
	<keyword>Iron overload</keyword>
	<keyword>Stem cell transplant</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Pediatric Stem cell transplant</keyword>
</DOC>